INMT and schizophrenia: Dysregulation in the enzymatic activity of INMT results in elevated levels of methylated indole alkylamines, including DMT and its psychoactive analogs, such as 5-hydroxy-DMT (bufotenine) and 5-methoxy-DMT, in individuals with schizophrenia [4,13].